SMRUTHIORG logo

Smruthi Organics Ltd

SMRUTHIORG·BSE·
₹140.50▼ -6.50 (-4.42%)
Market Cap162.48 Cr
PE Ratio46.99
Volume1,734
Day High - Low158.95 - 139.65
52W High-Low175.30 - 95.00

Smruthi Organics Ltd (SMRUTHIORG): company summary

The company's business has shown mixed performance, with annual revenue declining by -19.1% and annual net profit falling by -3.7%.

Smruthi Organics Ltd (SMRUTHIORG) is a micro-cap Healthcare company valued at ₹162 crore operating in Pharmaceuticals on the NSE and BSE.

Recent price move
Smruthi Organics Ltd last traded at ₹140.5, down 4.42% on the day.
Recent developments
2026-09-30: Promoter holding remained at 64.73%, indicating no change in ownership structure. 2026-06-30: The company reported a net profit of ₹3 crore for the latest quarter, reversing a net loss of ₹1 crore in the same period a year earlier.
Financial performance
The company's business has shown mixed performance, with annual revenue declining by -19.1% and annual net profit falling by -3.7%. However, the latest quarter saw a significant turnaround, with revenue rising 54.3% compared to the same quarter a year earlier and net profit swinging from a loss of ₹1 crore to a profit of ₹3 crore.
Valuation multiples
The stock trades at 47.0 times earnings, a premium to the Healthcare median of 32.0, 2.51 times book value. It yields 0.9%.
Things to watch
The company's annual revenue has declined by -19.1% year-over-year, and its profit has also fallen by -3.7%. Additionally, the stock is 16.1% below its 52-week high, and the company's profit growth over the past five years has been negative at -27.4%.
Where it stands
Smruthi Organics Ltd ended the latest quarter with a net profit of ₹3 crore, reversing a loss from the same period a year earlier. The stock is 16.1% below its 52-week high, and annual revenue has declined by -19.1%.

Summarised by DocStoX's model on 2026-10-18 from company filings, exchange data and news. This is a factual summary, not a rating or a recommendation. Informational only, not investment advice. Consult a SEBI-registered adviser before investing.

DocStoX Score
2.5/10
Poor
Fair Value
Sign in to see
ROE
4.66%
Weak
P/E
46.99x
Expensive
Debt / Equity
0.11
Low
Industry
Healthcare
Pharmaceuticals
Overall View
Mixed

Price performance

Day₹139.65
₹158.95
52W₹95.00
₹175.30
DocStoX take

Supported by risk (7.8) and momentum (6.0), but held back by growth (0.0). Risk looks strong at 7.8, but that is offset by valuation at 0.0 and growth at 0.0. We are calling it Mixed rather than resolving the conflict for you.

DocStoX score

Low confidence
2.5
/10
Poor
Quality
Modest
ROE 4.7%
Valuation
Expensive
P/E 47.0×
Growth
Flat
Revenue -4.1% 5Y CAGR
Risk
Low risk
D/E 0.11
Momentum
Firm
57% of 52-week range

At a glance

Market Cap
₹162 Cr
52W High / Low
₹175 / ₹95
Dividend Yield
0.93%
Promoter Holding
64.73%
EPS (TTM)
₹2.99
Book Value
₹64.22

Key highlights

  • Low leverage — D/E 0.11
  • Profitable in all of the last 5 years
  • Profit shrinking 27% a year
  • Revenue shrinking 4% a year
2 Positives4 Watchouts

Growth

Financials

Shareholding

Technicals

Peers

News

Forecasts

About the company

More data

Filings, corporate actions and ownership detail — opened on demand.

More Healthcare stocks · Pharmaceuticals

Smruthi Organics Ltd peers in Healthcare

Other Healthcare stocks on the NSE & BSE. See the full Healthcare sector list.